DOP52 Reduction in inflammatory biomarkers in a Phase 2 study of mirikizumab in patients with moderately to severely active ulcerative colitis
DOI
オープンアクセス
この論文をさがす
収録刊行物
-
- Journal of Crohn's and Colitis
-
Journal of Crohn's and Colitis 13 S059-S060, 2019-01-25
Oxford University Press (OUP)